Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alphatec Holdings, Inc. Director's Dealing 2018

Mar 16, 2018

31614_dirs_2018-03-16_102bec4c-166c-4857-b8c8-0ea15233b79d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Alphatec Holdings, Inc. (ATEC)
CIK: 0001350653
Period of Report: 2018-03-08

Reporting Person: L-5 Healthcare Partners, LLC (10% Owner, Director by deputization)
Reporting Person: Segal Paul (10% Owner, Director by deputization)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series B Convertible Preferred Stock $0 Common Stock (7936508) Direct
Warrants (right to buy) $3.50 Common Stock (6746032) Direct

Footnotes

F1: Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained.

F2: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following the date that stockholder approval is obtained.

F3: Each of Jason Hochberg and Evan Bakst serve on the board of directors of the issuer as arepresentative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F4: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.